Advertisement

Browse Subject Areas

?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

Methotrexate

Tumor Necrosis Factor (TNF) blocking agents are associated with lower risk for Alzheimer’s disease in patients with rheumatoid arthritis and psoriasis

Mengshi Zhou, Rong Xu, David C. Kaelber, Mark E. Gurney

published 23 Mar 2020

Loading metrics information...

Metrics unavailable. Please check back later.

Patient preferences for maintenance therapy in Crohn’s disease: A discrete-choice experiment

Glen S. Hazlewood, Gyanendra Pokharel, Robert Deardon, Deborah A. Marshall, Claire Bombardier, George Tomlinson, Christopher Ma, Cynthia H. Seow, Remo Panaccione, Gilaad G. Kaplan

published 16 Jan 2020

Loading metrics information...

Metrics unavailable. Please check back later.

Disease activity and damage in patients with primary Sjogren’s syndrome: Prognostic value of salivary gland ultrasonography

Vera Milic, Jelena Colic, Andja Cirkovic, Svetlana Stanojlovic, Nemanja Damjanov

published 31 Dec 2019

Loading metrics information...

Metrics unavailable. Please check back later.

Real world, big data cost of pharmaceutical treatment for rheumatoid arthritis in Greece

Kyriakos Souliotis, Christina Golna, Chara Kani, Sofia Nikolaidi, Dimitrios Boumpas

published 12 Dec 2019

Loading metrics information...

Metrics unavailable. Please check back later.

Changes in intracellular folate metabolism during high-dose methotrexate and Leucovorin rescue therapy in children with acute lymphoblastic leukemia

Natanja Oosterom, Robert de Jonge, Desiree E. C. Smith, Rob Pieters, Wim J. E. Tissing, Marta Fiocco, Bertrand D. van Zelst, Marry M. van den Heuvel-Eibrink, Sandra G. Heil

published 17 Sep 2019

Loading metrics information...

Metrics unavailable. Please check back later.

Comparison of oral versus parenteral methotrexate in the treatment of rheumatoid arthritis: A meta-analysis

Andreea M. Bujor, Sahar Janjua, Michael P. LaValley, Josefina Duran, Jürgen Braun, David T. Felson

published 06 Sep 2019

Loading metrics information...

Metrics unavailable. Please check back later.

Assessing the relative efficacy of interleukin-17 and interleukin-23 targeted treatments for moderate-to-severe plaque psoriasis: A systematic review and network meta-analysis of PASI response

Laura M. Sawyer, Kinga Malottki, Celia Sabry-Grant, Najeeda Yasmeen, Emily Wright, Anne Sohrt, Emma Borg, Richard B. Warren

published 14 Aug 2019

Loading metrics information...

Metrics unavailable. Please check back later.

Increased methotrexate intolerance in juvenile idiopathic arthritis compared to acute lymphoblastic leukaemia in children

Nini Kyvsgaard, Torben Stamm Mikkelsen, Mikael Thastum, Anne Estmann Christensen, Peder Skov Wehner, Karsten Nysom, Troels Herlin

published 11 Jul 2019

Loading metrics information...

Metrics unavailable. Please check back later.

Drug tolerability and reasons for discontinuation of seven biologics in elderly patients with rheumatoid arthritis -The ANSWER cohort study-

Kosuke Ebina, Motomu Hashimoto, Wataru Yamamoto, Toru Hirano, Ryota Hara, Masaki Katayama, Akira Onishi, Koji Nagai, Yonsu Son, Hideki Amuro, Keiichi Yamamoto, Yuichi Maeda, Koichi Murata, Sadao Jinno, Tohru Takeuchi, Makoto Hirao, Atsushi Kumanogoh, Hideki Yoshikawa

published 08 May 2019

Loading metrics information...

Metrics unavailable. Please check back later.

Preventing rheumatoid arthritis: Preferences for and predicted uptake of preventive treatments among high risk individuals

Mark Harrison, Luke Spooner, Nick Bansback, Katherine Milbers, Cheryl Koehn, Kam Shojania, Axel Finckh, Marie Hudson

published 25 Apr 2019

Loading metrics information...

Metrics unavailable. Please check back later.

The comparative responsiveness of Hospital Universitario Princesa Index and other composite indices for assessing rheumatoid arthritis activity

Isidoro González-Álvaro, Isabel Castrejón, Loreto Carmona, on behalf of ACT-RAY, PROAR and EMECAR study groups

published 10 Apr 2019

Loading metrics information...

Metrics unavailable. Please check back later.

Causes of synthetic disease-modifying drug discontinuation in rheumatoid arthritis: Data from a large real-life cohort

Ana Paula Monteiro Gomides, Cleandro Pires de Albuquerque, Ana Beatriz Vargas Santos, Rodrigo Balbino Chaves Amorim, Manoel Barros Bértolo, Paulo Louzada Júnior, Isabela Araújo Santos, Rina Dalva Neubarth Giorgi, Nathalia de Carvalho Sacilotto, Sebastião Cezar Radominski, Fernanda Maria Borghi, Maria Fernanda B. Resende Guimarães, Maria Raquel da Costa Pinto, Gustavo Gomes Resende, Karina Rossi Bonfiglioli, Henrique Carriço da Silva, Maria de Fátima Lobato da Cunha Sauma, Marcel Lobato Sauma, Júlia Brito de Medeiros, Ivânio Alves Pereira, Gláucio Ricardo Wernwer de Castro, Claiton Viegas Brenol, Ricardo Machado Xavier, Licia Maria Henrique da Mota, Geraldo da Rocha Castelar Pinheiro

published 01 Mar 2019

Loading metrics information...

Metrics unavailable. Please check back later.

Low dose naltrexone: Effects on medication in rheumatoid and seropositive arthritis. A nationwide register-based controlled quasi-experimental before-after study

Guttorm Raknes, Lars Småbrekke

published 14 Feb 2019

Loading metrics information...

Metrics unavailable. Please check back later.

Advertisement

Create a weekly email alert for: Methotrexate

You can change these options by clicking profile then "Alerts and Notifications"